Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04303494
Other study ID # 2018-01207; ks17Schulzke
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 1, 2018
Est. completion date November 5, 2022

Study information

Verified date March 2023
Source University Hospital, Basel, Switzerland
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study are to investigate whether heart rate variability (HRV) parameters derived from nonlinear time series analysis at five different time points have prognostic utility for assessing the risk of postimmunisation AOP in very preterm/very low birth weight infants immunised in the hospital.


Recruitment information / eligibility

Status Completed
Enrollment 292
Est. completion date November 5, 2022
Est. primary completion date November 5, 2022
Accepts healthy volunteers
Gender All
Age group 3 Days to 28 Days
Eligibility Inclusion criteria for preterm infants: - Gestational Age (GA) 22+0 to 31+6 weeks and/or birth weight 400 g to 1500 g - Chronological age > 7 days - Written informed parental consent Inclusion criteria for term healthy control infants: - GA 37 to 42 weeks, chronological age 3 to 28 days (beyond initial transition after birth) - Hospitalised in the neonatal rooming-in unit of the University Children's Hospital Basel as healthy co-twin or healthy sibling, or neonate ready to be discharged home after reconvalescence from minor illness such as hyperbilirubinaemia - Written informed parental consent Exclusion Criteria: - Major congenital malformations including neuromuscular disorders, thoracic malformations, major cardiac malformation - Lack of written informed parental consent

Study Design


Related Conditions & MeSH terms

  • Bradycardia
  • Post-immunisation Apnoea and Bradycardia of Prematurity (AOP)

Intervention

Biological:
immunisation
combined diphtheria, tetanus, acellular pertussis, poliomyelitis, hepatitis B, ± Haemophilus influenzae type B and simultaneous pneumococcus (PCV13) vaccination

Locations

Country Name City State
Switzerland University Children's Hospital Basel UKBB, University of Basel Basel

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in AOP Difference in AOP events within 24 hours after - 24 hours before immunisation record the sum of AOP events from 48 hours windows of raw data, within 24 hours after - 24 hours before immunisation
Secondary Difference in prolonged hypoxaemic episodes Difference in prolonged hypoxaemic episodes (SpO2 < 80% for at least 1 min) within 24 hours after - 24 hours before immunisation (CAP-trial definition). record SpO2 from 48 hours windows of raw data, within 24 hours after - 24 hours before immunisation
Secondary Difference in number of manual stimulations Difference in number of manual stimulations within 24 hours after - 24 hours before immunisation number of manual stimulations within 24 hours after - 24 hours before immunisation
Secondary Difference in number increases in oxygen concentration Difference in number increases in oxygen concentration within 24 hours after - 24 hours before immunisation record oxygen concentration from 48 hours windows of raw data, within 24 hours after - 24 hours before immunisation
Secondary Difference in number of increases in continuous positive airway pressure (CPAP) Difference in number of increases in continuous positive airway pressure (CPAP) within 24 hours after - 24 hours before immunisation within 24 hours after - 24 hours before immunisation
Secondary Difference in number of reinstallations in continuous positive airway pressure (CPAP) Difference in number of reinstallations in continuous positive airway pressure (CPAP) within 24 hours after - 24 hours before immunisation within 24 hours after - 24 hours before immunisation
Secondary Difference in number of endotracheal intubation Difference in number of endotracheal intubation for AOP events within 24 hours after - 24 hours before immunisation within 24 hours after - 24 hours before immunisation
Secondary Difference in sample entropy (SampEn) of interbeat interval of heart rate (IBI) Difference in SampEn of IBI 24 hours after - immediately prior to immunisation 24 hours after - immediately prior to immunisation
Secondary Difference in SampEn of IBI Difference in SampEn of IBI in preterm infants measured at 37 to 42 weeks postconceptional age vs. SampEn of IBI in term healthy control infants preterm infants measured at 37 to 42 weeks